Literature DB >> 2454080

Production of monoclonal antibodies with specificity for different epitopes on the human epidermal growth factor molecule.

Y Yoshitake1, K Nishikawa.   

Abstract

Four different monoclonal antibodies (MAbs) to human epidermal growth factor (hEGF) were obtained from mouse hybridoma cell lines. They were highly specific for hEGF and did not cross-react appreciably with mouse EGF. The immunoglobulin class of these MAbs was IgG1 or IgG2a. The apparent Kd values for hEGF of these MAbs ranged from 10(-10) to 10(-9) M. These MAbs all inhibited DNA synthesis in BALB/c3T3 cells stimulated by hEGF and 125I-labeled hEGF binding to the receptor of the cells. Reduction of hEGF with dithiothreitol decreased its reactivity with these MAbs, suggesting that they recognized the conformation of the hEGF molecule maintained by the three disulfide bonds. By competitive binding experiments with hEGF, these four MAbs were classified into three groups: two binding to an A domain of hEGF, one to a B domain, and one to a C domain and preventing the bindings of the other MAbs at the A and B domains. When a methionyl residue of hEGF was removed by its treatment with CNBr, the immunological reactivity of the C domain, but not the A or B domain, was destroyed in association with a decrease in the biological activity of the growth factor. These MAbs should be useful in studies on the structure-function relationship of hEGF.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2454080     DOI: 10.1016/0003-9861(88)90656-x

Source DB:  PubMed          Journal:  Arch Biochem Biophys        ISSN: 0003-9861            Impact factor:   4.013


  9 in total

1.  The membrane-anchoring domain of epidermal growth factor receptor ligands dictates their ability to operate in juxtacrine mode.

Authors:  Jianying Dong; Lee K Opresko; William Chrisler; Galya Orr; Ryan D Quesenberry; Douglas A Lauffenburger; H Steven Wiley
Journal:  Mol Biol Cell       Date:  2005-04-13       Impact factor: 4.138

2.  Basic fibroblast growth factor in rat salivary glands.

Authors:  O Amano; Y Yoshitake; K Nishikawa; S Iseki
Journal:  Cell Tissue Res       Date:  1993-09       Impact factor: 5.249

3.  Direct effect of basic fibroblast growth factor on gene transcription in a cell-free system.

Authors:  Y Nakanishi; K Kihara; K Mizuno; Y Masamune; Y Yoshitake; K Nishikawa
Journal:  Proc Natl Acad Sci U S A       Date:  1992-06-15       Impact factor: 11.205

4.  Distribution of fibroblast growth factors in cultured tumor cells and their transplants.

Authors:  Y Yoshitake; K Nishikawa
Journal:  In Vitro Cell Dev Biol       Date:  1992-06

5.  Monoclonal antibodies against heparin-binding growth factor II/basic fibroblast growth factor that block its biological activity: invalidity of the antibodies for tumor angiogenesis.

Authors:  K Matsuzaki; Y Yoshitake; Y Matuo; H Sasaki; K Nishikawa
Journal:  Proc Natl Acad Sci U S A       Date:  1989-12       Impact factor: 11.205

6.  Ultraviolet B-induced expression of amphiregulin and growth differentiation factor 15 in human lens epithelial cells.

Authors:  Hiromi Osada; Yoshino Yoshitake; Takayuki Ikeda; Yasuhito Ishigaki; Takanobu Takata; Naohisa Tomosugi; Hiroshi Sasaki; Hideto Yonekura
Journal:  Mol Vis       Date:  2011-01-13       Impact factor: 2.367

7.  Apical enrichment of human EGF precursor in Madin-Darby canine kidney cells involves preferential basolateral ectodomain cleavage sensitive to a metalloprotease inhibitor.

Authors:  P J Dempsey; K S Meise; Y Yoshitake; K Nishikawa; R J Coffey
Journal:  J Cell Biol       Date:  1997-08-25       Impact factor: 10.539

8.  Production of basic fibroblast growth factor-like factor by cultured human cholangiocellular carcinoma cells.

Authors:  K Matsuzaki; Y Yoshitake; M Miyagiwa; M Minemura; M Tanaka; H Sasaki; K Nishikawa
Journal:  Jpn J Cancer Res       Date:  1990-04

9.  Removal of the membrane-anchoring domain of epidermal growth factor leads to intracrine signaling and disruption of mammary epithelial cell organization.

Authors:  H S Wiley; M F Woolf; L K Opresko; P M Burke; B Will; J R Morgan; D A Lauffenburger
Journal:  J Cell Biol       Date:  1998-11-30       Impact factor: 10.539

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.